Trial Profile

Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 20 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary)
Indications Retinal oedema
Focus Proof of concept; Therapeutic Use
Sponsors Kiora Pharmaceuticals

Most Recent Events

24 Jun 2016 Status changed from recruiting to discontinued.
13 May 2016 Top-line data from this trial are expected in the second quarter of 2016, according to an Eyegate Pharmaceuticals media release.
19 Jan 2016 Planned End Date changed from 1 Mar 2016 to 1 Aug 2016 ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com